NEW YORK, April 28, 2022 (GLOBE NEWSWIRE) — Cycle for Survival, the movement to beat rare cancers, has made history by surpassing $300 million in total funds raised through its signature stationary cycling events . Since 2007, more than one million participants worldwide, including patients, caregivers, survivors, as well as Memorial Sloan Kettering clinicians, researchers, staff and administrators, have taken part in events to raise funds for rare cancer research at MSK. This new milestone highlights the unwavering determination of every rider, donor and supporter, as well as the tremendous collaborative effort between the entire Cycle for Survival community.

The $300 million raised by the Cycle for Survival community has empowered hundreds of doctors, scientists and musculoskeletal researchers to pursue bold ideas and transform the way cancer is diagnosed and treated. Cycle for Survival funding has directly supported many MSK innovations, including:

  • MSK-IMPACT®, a diagnostic tool capable of detecting mutations and other critical changes in the genes of rare cancers
  • Theranostics, a rare form of cancer treatment that harnesses the power of unique radioactive compounds to deliver treatments at the time of diagnosis
  • Immunotherapy, which uses the immune system to attack cancer cells the same way it attacks bacteria or viruses

“Two of the most important advances that have kept me alive in the past year have been fully funded by Cycle for Survival,” said David Ingerman, an MSK patient and Cycle for Survival participant. All funds raised by Cycle for Survival are allocated within six months of the close of fundraising. The funds go directly to MSK for research and clinical trials in rare cancers, which affect approximately half of all people with cancer and include all childhood cancers as well as cancers of the thyroid, brain, ovary and pancreas, among others.

“The fierce dedication of the entire Cycle for Survival community is a constant reminder to think outside the box, collaborate, and deliver new ideas that offer hope to people living with rare cancers,” said Craig B. Thompson, MD, President and Chief. Managing Director of MSK.

Equinox has been essential to the success of Cycle for Survival since day one as a founding partner. “From our humble but mighty beginnings to our explosive growth and surpassing $300 million, this movement is so unique because of every person, team and dollar working so hard to fight rare cancers,” said Scott Rosen, Advisor executive of Equinox.

Cycle for Survival was started by MSK patient and Equinox member Jennifer Goodman Linn and her husband, Dave Linn. Sixteen years ago, they gathered a group of friends and family for an indoor bike ride in New York City. With just 230 people and 50 bikes, they raised $250,000 for rare cancer research. This year, the high-energy stationary bike events are led by Equinox Group instructors in April and May at 15 outdoor locations across the country. Visit to learn more.


About Cycle for Survival

JOIN THE BATTLE. Cycle for Survival is the movement to defeat rare cancers. Since 2007, Cycle for Survival has raised $300 million through its stationary cycling events and virtual event experiences to help fund pioneering rare cancer research at MSK, which owns and operates Cycle for Survival. 100% of each donation funds research on rare cancers. About half of all people with cancer are battling a rare cancer and are often faced with limited or no treatment options. Together with the movement’s founding partner, Equinox, Cycle for Survival has supported innovative clinical trials, research studies and major scientific initiatives. For research updates and additional information, visit and follow Cycle for Survival on Facebook, Twitter, Instagram, LinkedIn and YouTube.

About Memorial Sloan Kettering Cancer Center

As the oldest and largest private cancer center in the world, MSK has dedicated more than 135 years to exceptional patient care, influential educational programs and innovative research to discover more effective strategies to prevent, control and ultimately cure cancer. MSK is home to more than 20,000 doctors, scientists, nurses and staff united by a relentless dedication to beating cancer. Today, we are one of 52 National Cancer Institute-designated comprehensive cancer centers, with cutting-edge science and technology supporting groundbreaking clinical studies, personalized treatment, and compassionate care for our patients. We also train the next generation of clinical and scientific leaders in oncology through our ever-evolving educational programs here and around the world. Year after year, we are ranked as one of the top two cancer hospitals in the country and consistently recognized for our expertise in adult and pediatric oncology specialties. For more information, visit

About Equinox

THIS IS NOT THE SHAPE. IT’S LIFE: Founded in 1991, Equinox was built on the notion that fitness can enable a life well lived and foster a strong community of high performing individuals. Nearly 30 years later, Equinox continues to lead and disrupt the category it uniquely defines, operating more than 100 full-service clubs worldwide in major US cities including New York, Los Angeles, Miami and San Francisco, as well as London, Toronto and Vancouver, each featuring bespoke design in unparalleled luxury surroundings. Founded on the fundamental principles of movement, nutrition and regeneration and supported by a health advisory board comprised of leading experts in these disciplines, the company offers an integrated Equinox+ membership model, which merges digital experiences and physics of Equinox. The dynamic membership builds on the vaunted in-club offering and Equinox+, a one-of-a-kind multi-brand digital platform offering premium fitness content across its portfolio of brands. In 2019, Equinox unveiled Equinox Hotels as a true culmination of its lifestyle brand promise, redefining the luxury hotel experience as a seamless extension of high performance living. For more information, visit


Maggie Hopf Cycle for Survival/Memorial Sloan Kettering Cancer Center 646-227-6071 [email protected]

Comments are closed.